サーバリックス2回目の後に、ポッツとなり、アドレナリン受容体抗体とムスカリン性アセチルコリン受容体抗体が陽性であった症例 (おそらく米国)
以前もリンクした論文ですが、要約の部分には、NMDA受容体抗体しか書いてありません。しかも血清のみで低レベル。
A previously healthy 18-year-old woman developed fatigue, pre-syncope, dizziness and nausea 48 h after vaccination with HPV vaccine, Cervarix. The symptoms were initially mild and were not attributed to vaccination. She subsequently received a second HPV vaccine 6 weeks after the first injection. Her symptoms immediately intensified, and she became bed-bound with pre-syncope, dizziness, nausea, sore throat, difficulty falling asleep, frequent awakenings during the night, visual disturbance, transient episodes of confusion and difficulty concentrating. She was unable to attend school and after seeing numerous specialists was diagnosed with chronic fatigue syndrome.
Autoimmune markers were negative for antinuclear anti- bodies (ANA), anti-SSA and anti-SSB antibodies, anti- TPO antibodies, anti-thyroglobulin antibodies, anti-phos- holipid antibodies and anti-DS DNA antibodies, but posi- tive for low level of anti-NMDAR Ab (performed by Oxford University Hospital Laboratory, UK; normal range: no antibodies detected). Further testing demonstrated positive beta 2 adrenergic and M2 muscarinic receptor antibodies (Berlin Cures, Germany). A paraneoplastic panel, including ganglionic AchR antibody, was negative. Serum anti-NMDA Ab were repeated 2 months later and were once again mildly elevated. To rule out a paraneoplastic syndrome with positive anti-NMDA Ab, a pelvic ultra- sound was obtained and did not reveal any ovarian or pelvic masses. Subsequently, a full body FDG-PET scan was performed and was also unremarkable. CSF analysis was negative for anti-NMDA Ab and other neuronal anti- bodies and showed normal cell count, glucose and protein. The patient received 5 treatments with plasmapheresis (血漿交換療法を5回)followed by a daily dose of prednisone(その後、プレドニゾロン毎日), and her symptoms improved significantly for about 7 weeks (7週間症状は改善したが、その後再発)after the treat- ment. When plasmapheresis was stopped and prednisone was tapered, the symptoms recurred. Following plasma- pheresis and prednisone treatment, a repeat serum anti- NMDAR Ab were negative. (血漿交換療法の後、NMDA受容体抗体は陰性)